Aug 2026
HMGB1/MYH9 suppresses PPARγ to induce lung injury in renal ischemia-reperfusion: protective effects of Rosiglitazone.
Clinically, elevated urinary CCL2 in critically ill children associates with higher risk of concurrent AKI/ALI and poorer prognosis, indicating CCL2 as a biomarker for treatment response and prognosis.
Dong-Ping Ning, Yu-Xian Kuai, Yue-Ying Zhou et al.
· Pediatric Research · 0 citations